These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 16709029

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model.
    Todhunter DA, Hall WA, Rustamzadeh E, Shu Y, Doumbia SO, Vallera DA.
    Protein Eng Des Sel; 2004 Feb; 17(2):157-64. PubMed ID: 15047912
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13.
    Rustamzadeh E, Vallera DA, Todhunter DA, Low WC, Panoskaltsis-Mortari A, Hall WA.
    J Neurooncol; 2006 May; 77(3):257-66. PubMed ID: 16314943
    [Abstract] [Full Text] [Related]

  • 5. Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme.
    Rustamzadeh E, Li C, Doumbia S, Hall WA, Vallera DA.
    J Neurooncol; 2003 Oct; 65(1):63-75. PubMed ID: 14649886
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of a bispecific biological drug designed to simultaneously target glioblastoma and its neovasculature in the brain.
    Oh S, Tsai AK, Ohlfest JR, Panoskaltsis-Mortari A, Vallera DA.
    J Neurosurg; 2011 Jun; 114(6):1662-71. PubMed ID: 21294620
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Targeting glioblastoma multiforme with an IL-13/diphtheria toxin fusion protein in vitro and in vivo in nude mice.
    Li C, Hall WA, Jin N, Todhunter DA, Panoskaltsis-Mortari A, Vallera DA.
    Protein Eng; 2002 May; 15(5):419-27. PubMed ID: 12034862
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of antiangiogenic targeted immunotoxin DTAT and DTATEGF against glioblastoma multiforme.
    Huang J, Yuan D, Liu D, Li J, Li Y, A Hall W, Li B.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Jan; 39(1):1-5. PubMed ID: 24473378
    [Abstract] [Full Text] [Related]

  • 15. Malignant progenitors from patients with CD87+ acute myelogenous leukemia are sensitive to a diphtheria toxin-urokinase fusion protein.
    Frankel AE, Beran M, Hogge DE, Powell BL, Thorburn A, Chen YQ, Vallera DA.
    Exp Hematol; 2002 Nov; 30(11):1316-23. PubMed ID: 12423685
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.
    Gondi CS, Lakka SS, Dinh DH, Olivero WC, Gujrati M, Rao JS.
    Clin Cancer Res; 2007 Jul 15; 13(14):4051-60. PubMed ID: 17634529
    [Abstract] [Full Text] [Related]

  • 20. Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment.
    Gao H, Yang Z, Cao S, Xiong Y, Zhang S, Pang Z, Jiang X.
    Biomaterials; 2014 Feb 15; 35(7):2374-82. PubMed ID: 24342723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.